BROWSE·page 1009 of 1443

Browse EX-10 agreements

17,311 total material contract exhibits.


EXHIBIT 10.2

SPLASH BEVERAGE GROUP, INC.

CANCELLATION AND EXCHANGE AGREEMENT

by and among

ARGENT BIOPHARMA LIMITED

(formerly known as MGC Pharmaceuticals Ltd)

MERCER STREET GLOBAL OPPORTUNITY FUND, LLC

and

SPLASH BEVERAGE GROUP, INC.

** **

Dated as of July 6, 2026

This CANCELLATION AND EXCHANGE AGREEMENT (this “Agreement”) is entered into as of July 6, 2026, by and among:

ARGENT BIOPHARMA LIMITED (ACN 637 530 498), a company organized under the laws of Australia, formerly known as MGC Pharmaceuticals Ltd (ACN 116 800 269), whose securities are listed on the Australian Securities Exchange under the ticker symbol ASX: RGT, with its principal office at ___________ (“RGT” or “Argent”);

MERCER STREET GLOBAL OPPORTUNITY FUND, LLC, a limited liability company organized under the laws of the State of Delaware, with its principal office at ___________ (“Mercer Street” or the “Investor”); and

…

EX-10.2·8-K·CIK 1553788·ACC 0001731122-26-000917·Filed Jul 06, 2026, 16:30 ET

EXHIBIT 10.1

SPLASH BEVERAGE GROUP, INC.

EXCLUSIVE LICENSE AGREEMENT

This Exclusive License Agreement (this “Agreement”) is entered into as of July 6, 2026 (the “Effective Date”), by and between:

Argent Biopharma Limited (ACN 637 530 498), a company organized and existing under the laws of the Commonwealth of Australia, listed on the Australian Securities Exchange (ASX: RGT), with its principal office at ___________ (“Licensor” or “RGT”); and

Splash Beverage Group, Inc., a corporation duly organized and existing under the laws of the State of Nevada, listed on NYSEA (NYSE American: SBEV), with its principal office at ___________ (“Licensee” or “SBEV”).

RGT and SBEV are each referred to herein individually as a “Party” and collectively as the “Parties.”

RECITALS

A.       RGT is a clinical-stage biopharmaceutical company engaged in the research, development, and commercialization of nano-engineered therapeutics targeting immune dysregulation in drug-resistant epilepsy and cytokine-driven inflammatory disorders.

…

EX-10.1·8-K·CIK 1553788·ACC 0001731122-26-000917·Filed Jul 06, 2026, 16:30 ET

EXHIBIT 10.1

CXApp Inc.

CXAI

Interim Chief Financial Officer Appointment Letter & Statement of Responsibilities

Employee: Melissa Podruzny

Title: Interim Chief Financial Officer

Effective Date: July 1st, 2026

Reporting To: Chief Executive Officer

Board Oversight: Audit Committee of the Board of Directors

Purpose

In connection with the Company’s acquisition and integration of EngineRoom and the ongoing optimization of the finance organization, Melissa Podruzny is hereby appointed as Interim Chief Financial Officer of CXApp Inc. (“Company”) for an initial three-month transition period.

The purpose of this appointment is to provide executive financial leadership, ensure continuity of financial operations, maintain compliance with SEC and Nasdaq reporting obligations, oversee post-acquisition financial integration activities, and support the Company’s broader strategic and operational objectives.

…

EX-10.1·8-K·CIK 1820875·ACC 0001829126-26-007295·Filed Jul 06, 2026, 16:30 ET

EX-10.1

Greystone Housing Impact Investors LP

INDEPENDENT CONTRACTOR AGREEMENT

This INDEPENDENT CONTRACTOR AGREEMENT(“Agreement”), is made effective as of July 1, 2026 (the “Effective Date”) by and between GREYSTONE HOUSING IMPACT INVESTORS LP(“Company”) and JESSE COURY, an individual (the “Contractor”). Company and Contractor are also referred to herein, individually, as a “Party” and, collectively, as the “Parties.”

WITNESSETH:

WHEREAS, the Company desires to enter into this Agreement with the Contractor, providing, among other things, for Contractor’s services to the Company; and

WHEREAS, the Contractor desires to enter into this Agreement with respect to Contractor’s services to the Company, upon the terms and conditions hereinafter set forth.

NOW, THEREFORE, in consideration of the foregoing statements, the provisions hereafter set forth in this Agreement and its exhibits and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

1.

…

EX-10.1·8-K·CIK 1059142·ACC 0001193125-26-296254·Filed Jul 06, 2026, 16:30 ET

EX-10.1

Targa Resources Corp.

**SEVENTEENTH AMENDMENT **

**TO **

**RECEIVABLES PURCHASE AGREEMENT **

THIS SEVENTEENTH AMENDMENT TO RECEIVABLES PURCHASE AGREEMENT, dated as of July 1, 2026 (this “Amendment”), is entered into by TARGA RECEIVABLES LLC, as seller (the “Seller”), TARGA RESOURCES PARTNERS LP (“Targa”), as servicer (in such capacity, together with its successors and permitted assigns in such capacity and any successor servicer designated in accordance with the terms of the Agreement, the “Servicer”), the various CONDUIT PURCHASERS signatory hereto, the various COMMITTED PURCHASERS signatory hereto, the various PURCHASER AGENTS signatory hereto, the various LC Participants signatory hereto and PNC BANK, NATIONAL ASSOCIATION, as administrator (in such capacity, together with its successors and assigns in such capacity, the “Administrator”) and as LC BANK and amends that certain Receivables Purchase Agreement (including all signature pages, exhibits, schedules and annexes thereto), dated as of January 10, 2013, as amended by the First Amendment to Receivables Purchase Agreement, dated as of Au

…

EX-10.1·8-K·CIK 1389170·ACC 0001193125-26-296255·Filed Jul 06, 2026, 16:30 ET

** **

**PLACEMENT AGENCY AGREEMENT **

July 3, 2026

Univest Securities, LLC

75 Rockefeller Plaza, Suite 25A

New York, NY 10019

Ladies and Gentlemen:

Subject to the terms and conditions of this agreement (this “Agreement”) and the Transaction Documents (as defined below), China SXT Pharmaceuticals, Inc., a BVI business company incorporated in the British Virgin Islands (the “Company”), hereby agrees to establish a private placement financing facility consisting of one or more pre-paid purchases for the purchase of Class A ordinary shares with no par value per share, of Company (the “Ordinary Shares”), in an aggregate principal amount of up to approximately $31,500,000, before deducting an original issue discount (the “OID”) of $1,500,000, directly with one or more accredited and/or institutional investors (each, an “Investor” and collectively, the “Investors”), through Univest Securities, LLC, as placement agent (the “Placement Agent”). The Offering is intended to be made as a private placement exempt from registration under the Securities Act pursuant to

…

EX-10.2·6-K·CIK 1723980·ACC 0001213900-26-075528·Filed Jul 06, 2026, 16:30 ET

Securities Purchase Agreement

This Securities Purchase Agreement (this “Agreement”), dated as of July 3, is entered into by and between CHINA SXT PHARMACEUTICALS INC., a British Virgin Islands business company (“Company”), and [*], a [*] company, its successors and/or assigns (“Investor”). Capitalized terms used but not otherwise defined herein will have the meanings set forth in Section 15.

A. Company and Investor are executing and delivering this Agreement in reliance upon an exemption from securities registration afforded by the Securities Act of 1933, as amended (the “1933 Act”), and the rules and regulations promulgated thereunder by the United States Securities and Exchange Commission (the “SEC”).

…

EX-10.1·6-K·CIK 1723980·ACC 0001213900-26-075528·Filed Jul 06, 2026, 16:30 ET

EX-10.1

Neutron Holdings, Inc.

CREDIT AGREEMENT

dated as of

July 2, 2026

by and among

NEUTRON HOLDINGS, INC.

as the Borrower

the Lenders and Issuing Banks party hereto,

JPMORGAN CHASE BANK, N.A.,

as Administrative Agent,

and

JPMORGAN CHASE BANK, N.A.,

CITIZENS BANK, N.A.

and GOLDMAN SACHS BANK USA,

as Joint Lead Arrangers and Joint Bookrunners


TABLE OF CONTENTS

…

EX-10.1·8-K·CIK 1699963·ACC 0001628280-26-047289·Filed Jul 06, 2026, 16:28 ET

EX-10.2

DLH Holdings Corp.

www.dlhcorp.com

            June 30, 2026

Steven Oroho

Dear Steve,

On behalf of DLH Holdings Corp. (“DLH”, or the “Company”), I am pleased to extend to you an offer of employment in the position of Chief Financial Officer. As discussed, the effective date of the commencement of your employment as Chief Financial Officer is July 1, 2026. Your role reports directly to the Chief Executive Officer of the Company, the Board of Directors of the Company, and the Audit Committee of the Company. In your capacity as the Chief Financial Officer of the Company, you are also being appointed as the Company’s Principal Accounting Officer and Treasurer as well as the Chief Financial Officer and Treasurer of all of the Company’s subsidiaries.

…

EX-10·8-K·CIK 785557·ACC 0001628280-26-047263·Filed Jul 06, 2026, 16:15 ET

EX-10.3

DLH Holdings Corp.

CHANGE IN CONTROL, SEVERANCE AND COVENANT AGREEMENT

This Change in Control, Severance and Covenant Agreement (the “Agreement”) is made and entered into by and between Steven Oroho (“Employee”) and DLH Holdings Corp., a New Jersey corporation (the “Company”), on June 30, 2026 (the “Execution Date”) and shall be effective as of July 1, 2026 (the “Effective Date”).

Recitals

WHEREAS, pursuant to an employment offer letter executed as of the Execution Date (the “Offer Letter”), Employee will be appointed as the Chief Financial Officer of the Company upon the Effective Date;

WHEREAS, the Employee has entered into that certain Employee Invention Assignment and Confidentiality Agreement dated June 27, 2026 (the “Assignment and Confidentiality Agreement”);

…

EX-10·8-K·CIK 785557·ACC 0001628280-26-047263·Filed Jul 06, 2026, 16:15 ET

EX-10.1

DLH Holdings Corp.

EXECUTIVE EMPLOYMENT AGREEMENT

THIS AGREEMENT is made as of the 30thday of June, 2026 by and between Kathryn M. JohnBull (the “Executive”) and DLH HOLDINGS CORP., a New Jersey corporation (the “Company”) and is effective as of the July 1, 2026 (the “Effective Date”).

W I T N E S S E T H:

WHEREAS, the Company and its subsidiaries are engaged in the business of providing professional and technical services; and

WHEREAS, the Executive is currently employed by the Company as the Chief Financial Officer of the Company, and the Company desires to continue the employment of the Executive as its Chief Executive Officer and President; and

WHEREAS, the Executive desires to continue her employment with the Company, pursuant to the terms and conditions herein set forth, superseding all prior oral and written employment agreements, and term sheets and letters between the Company, its subsidiaries and/or predecessors and Executive;

NOW, THEREFORE, it is mutually agreed by and between the parties hereto as follows:

ARTICLE I

DEFINITIONS

…

EX-10·8-K·CIK 785557·ACC 0001628280-26-047263·Filed Jul 06, 2026, 16:15 ET

Execution Version

CUSIP NO. 88738WAP8

REVOLVER CUSIP NO. 88738WAQ6

SIXTH AMENDED AND RESTATED

CREDIT AGREEMENT

Dated as of July 2, 2026

among

THE TIMKEN COMPANY

and

CERTAIN SUBSIDIARIES,

as the Borrowers,

BANK OF AMERICA, N.A. and JPMorgan Chase BANK, N.A.,

as Co-Administrative Agents,

KEYBANK NATIONAL ASSOCIATION

and

PNC BANK, NATIONAL ASSOCIATION,

as Co-Syndication Agents,

Wells Fargo Bank, National Association,

as Documentation Agent,

JPMorgan Chase BANK, N.A.,

as Paying Agent for the Non-EEA Agented Borrowers, L/C Issuer and Swing Line Lender,

J.P. MORGAN SE,

as Paying Agent for the EEA Agented Borrowers

and

The Other Lenders Party Hereto

BofA Securities, Inc.,

JPMORGAN CHASE BANK, N.A.,

KEYBANC CAPITAL MARKETS INC.

and

PNC Capital Markets LLC,

as

Joint Lead Arrangers and Joint Bookrunners

TABLE OF CONTENTS

Page

…

EX-10.1·8-K·CIK 98362·ACC 0001206774-26-000349·Filed Jul 06, 2026, 16:15 ET